Abdullah S Alanazi
Overview
Explore the profile of Abdullah S Alanazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abd El Mawgod M, Alanazi A, Alenezi N, Alrwaili M, Alsuqub S
Cureus
. 2024 May;
16(4):e58724.
PMID: 38784351
Background: One of the most prevalent types of cancer is colorectal cancer (CRC). Increased consumption of foods derived from animals, smoking, and family history are all regarded as CRC risk...
2.
Alanazi A, Almutairi H, Gupta J, Mohanty D, Rath D, AlOdan A, et al.
Bone Rep
. 2024 Feb;
20:101741.
PMID: 38348455
Background: Proton pump inhibitors (PPIs) are among the most commonly prescribed medications worldwide for acid-related disorders. While their short-term efficacy and safety are well-established, concerns regarding their long-term effects on...
3.
Alqahtani S, Ahmad S, Alam N, Syed N, Syed M, Khardali A, et al.
Saudi Pharm J
. 2023 May;
31(6):979-988.
PMID: 37234340
Background: Globally, adverse drug reactions (ADRs) are the foremost cause of morbidity as well as mortality. This necessitates a system of surveillance that can effectively and efficiently monitor the effect...
4.
Boshra M, Elgendy M, Abdelaty L, Tammam M, Alanazi A, Alzarea A, et al.
Int J Environ Res Public Health
. 2022 Dec;
19(24).
PMID: 36554688
Background: This study aimed to evaluate the Egyptian population's preference and awareness related to available COVID-19 vaccines and to determine different factors that can affect beliefs concerning these vaccines. Methods:...
5.
Abdelrahman M, Ahmed A, Alanazi A, Osama H
J Clin Med
. 2022 Sep;
11(17).
PMID: 36078893
Currently, there is no standardized consensus on anticoagulation (AC) among patients with coronavirus disease (COVID-19), which has an overwhelming bleeding risk. We aimed to compare the patterns of AC in...
6.
Khan Y, Mallhi T, Alanazi A, Butt M, Khan A, Salman M
J Med Virol
. 2022 Apr;
94(9):4063-4064.
PMID: 35488384
No abstract available.
7.
Abdelgawad M, Parambi D, Ghoneim M, Alotaibi N, Alzarea A, Alanazi A, et al.
Int Wound J
. 2022 Apr;
19(8):2092-2100.
PMID: 35445789
A meta-analysis was performed to assess the effect of surgical site wound infections and risk factors in neonates undergoing surgery. A systematic literature search up to January 2022 incorporated 17...
8.
Alzarea S, Alasmari A, Alanazi A, Alzarea A, Alharbi M, Alshammari A, et al.
Front Pharmacol
. 2022 Mar;
13:810052.
PMID: 35242033
The present research work was planned to evaluate the antioxidant and anti-inflammatory actions of butin in preventing complete Freund's adjuvant-induced arthritis in rats. Adult Wistar rats (200-240 g) were segregated...
9.
AlRuthia Y, Al-Salloum H, Almohammed O, Alqahtani A, Al-Abdulkarim H, Alsofayan Y, et al.
Vaccines (Basel)
. 2022 Feb;
10(2).
PMID: 35214781
Background: Saudi Arabia expedited the approval of some COVID-19 vaccines and launched mass vaccination campaigns. The aim of this study was to describe the demographics of vaccinated COVID-19 cases and...
10.
Elgendy M, El-Gendy A, Alzarea A, Mahmoud S, Alqahtani S, Fahmy A, et al.
Vaccines (Basel)
. 2022 Jan;
10(1).
PMID: 35062679
Vaccines are the solution to overcome SARS-CoV-2. This study aimed to determine the post-Sinopharm vaccine safety-profile and immunity through antibody titers. Data were collected using a structured questionnaire from Egyptian...